Positive Interim Analysis of the FALCON Study 2024 SummaryImportant events during 2024KL1333In July, Abliva announced a positive outcome of the interim analysis of the 24-week data of the FALCON study ...

Stice to transition from role as Chief Executive Officer; Kaes Van't Hof, current President, will assume Chief Executive Officer role; Austen Gilfillian, current Vice Pr ...

This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to ...

Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) ...

BOULDER, Colo., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA) ("Gaia” or the "Company”), a conscious media and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

ALX On­col­o­gy is forg­ing ahead with a treat­ment ap­proach that has long been aban­doned by oth­er drug­mak­ers, eye­ing a po­ten­tial ac­cel­er­at­ed ap­proval path­way for ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has nominated Fabrice ...